Watch for Acid-Reducer Interactions With New Hep C Med Harvoni

Please see new warnings concerning the use of amiodarone with Harvoni or Sovaldi

    You'll see two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Olysio (simeprevir) PLUS Sovaldi (sofosbuvir).

   These new regimens are changing hep C therapy again...because they eliminate the need for ribavirin and interferon for most patients.

   Harvoni is a new once-daily tablet that combines Sovaldi with a new antiviral, ledipasvir.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote